Oleanolic acid inhibits aldo-keto reductase family 1 member B10-induced cancer stemness and avoids cisplatin-based chemotherapy resistance via the Snail signaling pathway in oral squamous cell carcinoma cell lines
Journal of Dental Sciences · 2025-01 · 20 (1) · 100-108
DOI: 10.1016/j.jds.2024.09.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Dental Sciences, 2025-01. Verfasst von Hui-Hsin Ko und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background/purpose: Oral squamous cell carcinoma (OSCC) is a common malignancy often associated with poor prognosis due to chemoresistance. In this study, we investigated whether arecoline, a major alkaloid in betel nuts, can stimulate aldo-keto reductase family 1 member B10 (AKR1B10) levels in OSCC, promoting cancer stemness and leading to resistance to cisplatin (CDDP)-based chemotherapy. Materials and methods: Gain- and Loss- of AKR1B10 functions were analyzed using WB and q-PCR of OSCC cells. Stemness, epithelial mesenchymal transition (EMT) markers, and CDDP drug resistance in overexpressed AKR1B10 were also identified.
Results
Upregulated AKR1B10 in OSCC significantly increased cell motility and aggregation. The results also showed that the canonical TGF-β1-Smad3 pathway was involved in arecoline-induced AKR1B10 expression, further increasing cancer stemness with CDDP resistance via the Snail-dependent EMT pathway. Moreover, oleanolic acid (OA) and ROS/RNS (reactive oxygen/nitrogen species) inhibitors effectively reversed AKR1B10-induced CDDP-resistance.
Conclusion
Arecoline-induced ROS/RNS to hyper-activate AKR1B10 in tumor sphere cells via the TGF-β1-Smad3 pathway. Furthermore, AKR1B10 enhanced CDDP resistance in OSCC cells via EMT-inducing markers. Finally, Finally, OA may efficiently target CDDP resistance, reverse stemness in OSCC cells, and have the potential as a novel anticancer drug.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan.
- Department of Dentistry, National Taiwan University Hospital, College of Medicine, Taipei, Taiwan.
- Department of Dentistry, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan.
- School of Dentistry, National Taiwan University, Taipei, Taiwan.
- Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University, Taipei, Taiwan.
Zitieren
APA
Ko, H. H., Chou, H. E., Hou, H. H., Kuo, W. T., Liu, W. W., Yen-Ping Kuo, M., & Cheng, S. J. (2025). Oleanolic acid inhibits aldo-keto reductase family 1 member B10-induced cancer stemness and avoids cisplatin-based chemotherapy resistance via the Snail signaling pathway in oral squamous cell carcinoma cell lines. Journal of Dental Sciences, 20(1), 100-108. https://doi.org/10.1016/j.jds.2024.09.018
Vancouver
Ko HH, Chou HE, Hou HH, Kuo WT, Liu WW, Yen-Ping Kuo M, et al. Oleanolic acid inhibits aldo-keto reductase family 1 member B10-induced cancer stemness and avoids cisplatin-based chemotherapy resistance via the Snail signaling pathway in oral squamous cell carcinoma cell lines. Journal of Dental Sciences. 2025;20(1):100-108. doi:10.1016/j.jds.2024.09.018
BibTeX
@article{Ko2025,
author = {Ko, Hui-Hsin and Chou, Han-Yi E and Hou, Hsin-Han and Kuo, Wei-Ting and Liu, Wei-Wen and Yen-Ping Kuo, Mark and Cheng, Shih-Jung},
title = {Oleanolic acid inhibits aldo-keto reductase family 1 member B10-induced cancer stemness and avoids cisplatin-based chemotherapy resistance via the Snail signaling pathway in oral squamous cell carcinoma cell lines},
journal = {Journal of Dental Sciences},
year = {2025},
volume = {20},
number = {1},
pages = {100--108},
doi = {10.1016/j.jds.2024.09.018}
}
EUVIMED